• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力患者血清白细胞介素-32α水平升高。

Elevated serum level of interleukin-32α in the patients with myasthenia gravis.

机构信息

Department of Neurology, Gangnam Severance Hospital, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, 146-92 Gangnam-gu, Seoul, 135-720, Republic of Korea.

出版信息

J Neurol. 2011 Oct;258(10):1865-70. doi: 10.1007/s00415-011-6036-7. Epub 2011 Apr 13.

DOI:10.1007/s00415-011-6036-7
PMID:21487807
Abstract

A new cytokine, interleukin-32 (IL-32), has been implicated in the pro-inflammatory immune responses in several autoimmune disorders, such as rheumatoid arthritis and inflammatory bowel diseases. Myasthenia gravis (MG) is a well-characterized autoimmune disease directed at the postsynaptic acetylcholine receptor (AChR) or end plate of the neuromuscular junction. IL-32 is a cytokine that induces tumor necrosis factor (TNF)-α, IL-6, IL-1β, and chemokine. IL-6, TNF-α, and IL-2 are related to the pathogenesis and immunoregulation of MG. The gene expression of IL-32 is increased in human natural killer (NK) cells and T lymphocytes when stimulated by IL-2 or mitogen. NK cells influence the development of experimental autoimmune MG (EAMG) and possibly MG. The aim of this study was to examine whether IL-32α levels are increased in patients with MG and to investigate the relationship between IL-32α levels and disease activity in human MG. Serum IL-32α levels were significantly higher in the MG patients (p = 0.03): 460.07 ± 192.30 pg/mL in MG patients and 248.45 ± 188.42 pg/mL in the healthy control group. Although there was no significant statistical difference, serum IL-32α levels of patients with both anti-AChR binding and blocking antibodies trended to be higher than those without either antibodies (521.56 ± 212.92 pg/mL vs. 339.52 ± 182.78 pg/mL, p = 0.16). IL-32α serum levels tended to decrease with clinical improvement in generalized MG. This study suggests the possibility that IL-32 might contribute to MG pathogenesis or immunoregulation.

摘要

一种新的细胞因子白细胞介素-32(IL-32)已被牵涉到几种自身免疫性疾病的促炎免疫反应中,如类风湿关节炎和炎症性肠病。重症肌无力(MG)是一种特征明确的自身免疫性疾病,针对的是神经肌肉接头的突触后乙酰胆碱受体(AChR)或终板。IL-32 是一种诱导肿瘤坏死因子(TNF)-α、IL-6、IL-1β和趋化因子的细胞因子。IL-6、TNF-α和 IL-2 与 MG 的发病机制和免疫调节有关。当受到 IL-2 或有丝分裂原刺激时,人类自然杀伤(NK)细胞和 T 淋巴细胞的 IL-32 基因表达增加。NK 细胞影响实验性自身免疫性 MG(EAMG)的发展,并可能影响 MG。本研究旨在探讨 MG 患者的 IL-32α 水平是否升高,并研究人类 MG 患者中 IL-32α 水平与疾病活动度的关系。MG 患者的血清 IL-32α 水平显著升高(p=0.03):MG 患者为 460.07±192.30pg/mL,健康对照组为 248.45±188.42pg/mL。尽管没有显著的统计学差异,但同时具有抗 AChR 结合和阻断抗体的患者的血清 IL-32α 水平趋势高于没有任何一种抗体的患者(521.56±212.92pg/mL 比 339.52±182.78pg/mL,p=0.16)。全身性 MG 患者的 IL-32α 血清水平随着临床改善而趋于下降。本研究表明,IL-32 可能有助于 MG 的发病机制或免疫调节。

相似文献

1
Elevated serum level of interleukin-32α in the patients with myasthenia gravis.重症肌无力患者血清白细胞介素-32α水平升高。
J Neurol. 2011 Oct;258(10):1865-70. doi: 10.1007/s00415-011-6036-7. Epub 2011 Apr 13.
2
Serum interleukin-27 expression in patients with myasthenia gravis.重症肌无力患者血清白细胞介素-27表达
J Neuroimmunol. 2015 Nov 15;288:120-2. doi: 10.1016/j.jneuroim.2015.09.010. Epub 2015 Sep 28.
3
[Expression of IL-21 in the peripheral blood of myasthenia gravis patients and its correlation with anti-AChR-Ab class switch].[重症肌无力患者外周血中白细胞介素-21的表达及其与抗乙酰胆碱受体抗体类别转换的相关性]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Sep;35(9):958-63. doi: 10.3969/j.issn.1672-7347.2010.09.010.
4
Increased serum interleukin-41 correlates with disease severity in myasthenia gravis.血清白细胞介素-41 水平升高与重症肌无力的疾病严重程度相关。
Int Immunopharmacol. 2024 Jun 15;134:112275. doi: 10.1016/j.intimp.2024.112275. Epub 2024 May 17.
5
CD4 T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS.重症肌无力患者的 CD4 T 细胞表现为 IL-21、IL-4 和 IL-17A 产生增加,以及 PD-1 和 ICOS 的高表达。
Front Immunol. 2020 May 19;11:809. doi: 10.3389/fimmu.2020.00809. eCollection 2020.
6
Serum cytokine and chemokine profiles in patients with myasthenia gravis.重症肌无力患者的血清细胞因子和趋化因子谱。
Clin Exp Immunol. 2014 May;176(2):232-7. doi: 10.1111/cei.12272.
7
The effect of interleukin (IL)-21 and CD4 CD25 T cells on cytokine production of CD4 responder T cells in patients with myasthenia gravis.白细胞介素(IL)-21和CD4 CD25 T细胞对重症肌无力患者CD4应答性T细胞细胞因子产生的影响。
Clin Exp Immunol. 2017 Nov;190(2):201-207. doi: 10.1111/cei.13006. Epub 2017 Jul 28.
8
Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.实验性自身免疫性重症肌无力的病理机制。II. 用抗乙酰胆碱受体抗体在大鼠中被动转移实验性自身免疫性重症肌无力
J Exp Med. 1976 Sep 1;144(3):739-53. doi: 10.1084/jem.144.3.739.
9
Changes in inflammatory cytokine networks in myasthenia gravis.重症肌无力中炎性细胞因子网络的变化
Sci Rep. 2016 May 13;6:25886. doi: 10.1038/srep25886.
10
Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis.在重症肌无力中,单核细胞中肿瘤坏死因子-α、淋巴毒素、白细胞介素(IL)-6、IL-10、IL-12和穿孔素mRNA对乙酰胆碱受体反应的表达增加。
J Neuroimmunol. 1996 Dec;71(1-2):191-8. doi: 10.1016/s0165-5728(96)00152-x.

引用本文的文献

1
Association Between Serum Interleukin-32 Level and Disease Status in Cases with Neuromyelitis Optica Spectrum Disorders.视神经脊髓炎谱系障碍患者血清白细胞介素-32水平与疾病状态的关联
J Inflamm Res. 2024 Aug 26;17:5645-5652. doi: 10.2147/JIR.S476435. eCollection 2024.
2
Lymphoplasmapheresis versus plasma exchange in severe myasthenia gravis: a retrospective cohort study.重症肌无力中淋巴细胞去除术与血浆置换的比较:一项回顾性队列研究
Front Neurol. 2023 Jun 27;14:1212868. doi: 10.3389/fneur.2023.1212868. eCollection 2023.
3
Human IL-32θA94V mutant attenuates monocyte-endothelial adhesion by suppressing the expression of ICAM-1 and VCAM-1 via binding to cell surface receptor integrin αVβ3 and αVβ6 in TNF-α-stimulated HUVECs.

本文引用的文献

1
Endogenous IL-32 controls cytokine and HIV-1 production.内源性白细胞介素-32控制细胞因子和HIV-1的产生。
J Immunol. 2008 Jul 1;181(1):557-65. doi: 10.4049/jimmunol.181.1.557.
2
Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.炎症性肠病中白细胞介素-32α的上皮细胞过表达。
Clin Exp Immunol. 2007 Sep;149(3):480-6. doi: 10.1111/j.1365-2249.2007.03439.x. Epub 2007 Jun 22.
3
Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32).最新白细胞介素对自身免疫的调节作用(特别强调白细胞介素-32)
人白细胞介素 32θA94V 突变体通过与 TNF-α 刺激的 HUVECs 表面受体整合素 αVβ3 和 αVβ6 结合,抑制 ICAM-1 和 VCAM-1 的表达,从而减弱单核细胞-内皮细胞黏附。
Front Immunol. 2023 May 9;14:1160301. doi: 10.3389/fimmu.2023.1160301. eCollection 2023.
4
Circulating and inducible IL-32α in chronic hepatitis C virus infection.慢性丙型肝炎病毒感染中循环及诱导性IL-32α
Can Liver J. 2019 Feb 25;2(1):23-30. doi: 10.3138/canlivj.2018-0003. eCollection 2019 Winter.
5
Comparison of the Seven Interleukin-32 Isoforms' Biological Activities: IL-32θ Possesses the Most Dominant Biological Activity.比较七种白细胞介素-32 同种型的生物学活性:白细胞介素-32θ 具有最显著的生物学活性。
Front Immunol. 2022 Feb 25;13:837588. doi: 10.3389/fimmu.2022.837588. eCollection 2022.
6
Increased Human Interleukin-32 Expression Is Related to Disease Activity of Graves' Disease.人白细胞介素-32表达增加与Graves病的疾病活动相关。
Front Endocrinol (Lausanne). 2019 Sep 26;10:613. doi: 10.3389/fendo.2019.00613. eCollection 2019.
7
Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells.白细胞介素-32α通过诱导骨髓基质细胞产生白细胞介素-6来促进多发性骨髓瘤细胞的增殖。
Oncotarget. 2017 Oct 7;8(54):92841-92854. doi: 10.18632/oncotarget.21611. eCollection 2017 Nov 3.
8
Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis.白细胞介素 32γ 通过增加成骨细胞中的 miR-29a 刺激骨形成并预防骨质疏松症的发生。
Sci Rep. 2017 Jan 12;7:40240. doi: 10.1038/srep40240.
9
Association of Plasma IL-32 Levels and Gene Polymorphisms with Systemic Lupus Erythematosus in Chinese Han Population.中国汉族人群血浆白细胞介素-32水平及基因多态性与系统性红斑狼疮的关联
Dis Markers. 2016;2016:2460206. doi: 10.1155/2016/2460206. Epub 2016 Feb 29.
10
IL-32 promotes angiogenesis.IL-32 促进血管生成。
J Immunol. 2014 Jan 15;192(2):589-602. doi: 10.4049/jimmunol.1202802. Epub 2013 Dec 11.
Autoimmun Rev. 2007 Jan;6(3):131-7. doi: 10.1016/j.autrev.2006.08.015. Epub 2006 Oct 16.
4
Myasthenia gravis: past, present, and future.重症肌无力:过去、现在与未来。
J Clin Invest. 2006 Nov;116(11):2843-54. doi: 10.1172/JCI29894.
5
IL-32, a novel cytokine with a possible role in disease.白细胞介素-32,一种可能在疾病中发挥作用的新型细胞因子。
Ann Rheum Dis. 2006 Nov;65 Suppl 3(Suppl 3):iii61-4. doi: 10.1136/ard.2006.058511.
6
IL-32, a proinflammatory cytokine in rheumatoid arthritis.白细胞介素-32,类风湿关节炎中的一种促炎细胞因子。
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3298-303. doi: 10.1073/pnas.0511233103. Epub 2006 Feb 21.
7
IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism.白细胞介素-32通过半胱天冬酶-1依赖性机制,与核苷酸寡聚化结构域(NOD)1和NOD2配体协同作用,以产生白细胞介素-1β和白细胞介素-6。
Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16309-14. doi: 10.1073/pnas.0508237102. Epub 2005 Oct 31.
8
Interleukin-32: a cytokine and inducer of TNFalpha.白细胞介素-32:一种细胞因子及肿瘤坏死因子α诱导剂。
Immunity. 2005 Jan;22(1):131-42. doi: 10.1016/j.immuni.2004.12.003.
9
Etanercept as monotherapy in patients with psoriasis.依那西普单药治疗银屑病患者。
N Engl J Med. 2003 Nov 20;349(21):2014-22. doi: 10.1056/NEJMoa030409.
10
Evolving concepts of rheumatoid arthritis.类风湿关节炎的概念演变
Nature. 2003 May 15;423(6937):356-61. doi: 10.1038/nature01661.